01—Abstract
Summary
Summary of the 10-Q filed January 29, 2021. Cited figures are marked; the original filing is the authoritative source.
Carpenter Technology Corporation (CRS) reported a challenging quarter ended December 31, 2020, marked by a significant net loss of $84.9 milliona, or $1.76 per diluted share.
This contrasts sharply with the prior year's net income of $38.8 millionb. The decline was primarily driven by a substantial goodwill impairment charge of $52.8 million related to the Additive reporting unit and the ongoing impacts of the COVID-19 pandemic, which led to a 39% decrease in net sales to $348.8 million. Despite the net loss, the company highlighted a strong free cash flow generation of $113.7 million for the six-month period, a significant improvement from the prior year, driven by working capital management and reduced capital expenditures.
The company also noted positive developments in securing long-term contracts within the Aerospace and Defense market and anticipates a gradual improvement in end-use market conditions in the second half of fiscal year 2021. Management is focused on cost reduction initiatives and strategic portfolio realignments to navigate the current environment and capitalize on future market recoveries.
02—Key points
Key Highlights
- Reported a net loss of $84.9 million ($1.76/share) for the quarter ended December 31, 2020, a significant decrease from the prior year's net income of $38.8 million ($0.79/share).
- Net sales declined by 39% to $348.8 million for the quarter, primarily due to lower demand in key end-use markets like Aerospace & Defense and Medical, exacerbated by the COVID-19 pandemic and the 737 MAX production halt.
- Recorded a significant goodwill impairment charge of $52.8 million for the Additive reporting unit within the Performance Engineered Products (PEP) segment.
- Generated $113.7 million in free cash flow for the six months ended December 31, 2020, a substantial improvement from a negative $91.0 million in the prior year period, driven by working capital improvements and reduced capital expenditures.
- The Specialty Alloys Operations (SAO) segment experienced a 38% decrease in net sales, contributing to an operating loss of $11.6 million for the quarter.
- The Performance Engineered Products (PEP) segment saw a 48% decrease in net sales, resulting in an operating loss of $7.2 million for the quarter.
- The company ended the period with strong total liquidity of $665.4 million, including $271.4 million in cash and cash equivalents.
03—One dollar
Follow one dollar
For each $1.00 of revenue in Q2 FY2021, Carpenter Technology Corp lost $0.24.
- Revenue$348.8M100.0%
- Cost of revenue−$342.8M98.3%
- Gross profit$6.0M1.7%
- Operating costs−$95.0M27.2%
- Operating income−$89.0M25.5%
- Interest, other & tax$4.1M1.2%
- Net income−$84.9M24.3%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2021filed January 29, 2021Financial Statements
Q2 FY2021 against Q2 FY2020
| Line item | Q2 FY2021Q2 FY2020 | Change |
|---|---|---|
| Revenue | $348.80M$573.00M | −39.1% |
| Cost of Revenue | $342.80M$460.40M | −25.5% |
| Gross Profit | $6.00M$112.60M | −94.7% |
| SG&A Expenses | $42.20M$55.30M | −23.7% |
| Operating Income | -$89.00M$55.00M | −261.8% |
| Interest Expense | $7.90M$5.30M | +49.1% |
| Net Income | -$84.90M$38.80M | −318.8% |
| EPS (Basic) | $-1.76$0.80 | −320.0% |
| EPS (Diluted) | $-1.76$0.79 | −322.8% |
| Shares Outstanding (Basic) | 48.30M48.10M | +0.4% |
| Shares Outstanding (Diluted) | 48.30M48.50M | −0.4% |
05—Questions
Frequently Asked Questions
What was the primary driver of the significant net loss in the current quarter?
The primary driver of the significant net loss of $84.9 million was a $52.8 million goodwill impairment charge related to the Additive reporting unit within the Performance Engineered Products segment. This impairment was due to slower-than-expected growth, influenced by customer focus shifts and the impacts of the COVID-19 pandemic.
How has the COVID-19 pandemic impacted the company's sales?
The COVID-19 pandemic has had a significant negative impact on sales, leading to lower demand across all end-use markets. This resulted in a 39% decrease in net sales for the quarter, with particular weakness noted in the Aerospace & Defense and Medical segments due to travel restrictions, aircraft production halts, and delays in elective medical procedures.
What is the company's outlook for the near future?
While the current quarter was challenging, the company anticipates gradual improvement in end-use market conditions in the second half of fiscal year 2021. They have secured beneficial long-term contracts in the Aerospace and Defense market and are positioned to benefit from a recovery in the Medical market. Management is focused on cost reduction and strategic realignments to navigate the current environment and capitalize on future demand.
How did the company's cash flow performance compare to the previous year?
The company demonstrated a strong improvement in cash flow generation. For the six months ended December 31, 2020, free cash flow was a positive $113.7 million, a significant turnaround from a negative $91.0 million in the same period last year. This improvement was driven by better working capital management, including a significant reduction in inventory, and lower capital expenditures.
06—Continue